Sveriges mest populära poddar
Exchanges
Näringsliv

Vaccine Progress and What’s Next

10 min•12 november 2020

Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Fler avsnitt av Exchanges

Visa alla avsnitt av Exchanges
Apollo's Jim Zelter on the Future of Private Credit
•38 min
Why Aren’t Investors More Worried?
•20 min
Natural Gas in Focus: Iran Conflict Could Have ‘Very Painful’ Consequences
•16 min
AI Exchanges: Power Problems?
•20 min
The Business Builder: New Mountain Capital's Steve Klinsky
•35 min
Iran Conflict: How Long, and How Bad?
•20 min
Private Credit Concerns in Context
•31 min
Lloyd Blankfein on His Memoir Streetwise, Risk Management and Leadership
•31 min
Emerging Markets: Stirred, But Not Yet Shaken
•15 min
Goldman Sachs International’s Co-CEOs on Europe’s Opportunity, AI, and Market Volatility
•27 min

Exchanges med Goldman Sachs finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.